Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imran G House

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Immunity|July 1, 2023
Single-cell protein expression profiling resolves circulating and resident memory T cell diversity across tissues and infection contextsMaximilien Evrard, Etienne Becht, Raissa Fonseca, et al.
Nature Communications|May 29, 2021
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacyLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint BlockadeImran G House, Peter Savas, Junyun Lai, et al.
Nature Immunology|May 20, 2020
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunityJunyun Lai, Sherly Mardiana, Imran G House, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2020
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid TumorsLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Cancer Cell|September 30, 2022
Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responsesKah Lok Chan, Juliana Gomez, Chelisa Cardinez, et al.
Nature Communications|November 2, 2023
A<sub>2A</sub>R eGFP reporter mouse enables elucidation of A<sub>2A</sub>R expression dynamics during anti-tumor immune responsesKirsten L Todd, Junyun Lai, Kevin Sek, et al.
Cell Reports|August 22, 2023
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunityImran G House, Emily B Derrick, Kevin Sek, et al.
Nature Immunology|February 10, 2026
Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8<sup>+</sup> T cells in lymph nodesJunyun Lai, Cheok Weng Chan, Jesse D Armitage, et al.
Nature Communications|August 7, 2021
MAIT cells regulate NK cell-mediated tumor immunityEmma V Petley, Hui-Fern Koay, Melissa A Henderson, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Immunity|July 1, 2023
Single-cell protein expression profiling resolves circulating and resident memory T cell diversity across tissues and infection contextsMaximilien Evrard, Etienne Becht, Raissa Fonseca, et al.
Nature Communications|May 29, 2021
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacyLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint BlockadeImran G House, Peter Savas, Junyun Lai, et al.
Nature Immunology|May 20, 2020
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunityJunyun Lai, Sherly Mardiana, Imran G House, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2020
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid TumorsLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Cancer Cell|September 30, 2022
Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responsesKah Lok Chan, Juliana Gomez, Chelisa Cardinez, et al.
Nature Communications|November 2, 2023
A<sub>2A</sub>R eGFP reporter mouse enables elucidation of A<sub>2A</sub>R expression dynamics during anti-tumor immune responsesKirsten L Todd, Junyun Lai, Kevin Sek, et al.
Cell Reports|August 22, 2023
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunityImran G House, Emily B Derrick, Kevin Sek, et al.
Nature Immunology|February 10, 2026
Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8<sup>+</sup> T cells in lymph nodesJunyun Lai, Cheok Weng Chan, Jesse D Armitage, et al.
Nature Communications|August 7, 2021
MAIT cells regulate NK cell-mediated tumor immunityEmma V Petley, Hui-Fern Koay, Melissa A Henderson, et al.
Pageof 3